FDA Inspection 808119 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on Nov 12, 2012 in Ingelheim am Rhein. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 12, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ingelheim am Rhein (Germany)